logo

Marksans Pharma Ltd. Financials

10:39 Jun 19

Marksans Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
246.30
-3.85 (-1.54%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Marksans Pharma Ltd. Financials

Marksans Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
246.30
-3.85 (-1.54%)
10:39 Jun 19
Quality
image/svg+xml

61/100
High Financial Strength

Valuation
image/svg+xml

37/100
Mid Valuation

Technical

45/100
Technically Neutral

Strength

5

Weakness

2

Opportunity

1

Threats

0

15.42 %

ROE %

11.74 %

ROA %

8.40

EPS

54.44

BVPS

14.51 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
1376.18 1490.84 1852.14 2177.41 2622.84
Operating Expenses +
1036.57 1231.95 1512.82 1718.83 2094.2
Raw Material
731.33 703.92 927.75 1111.98 1327.5
Increase Decrease in Cost
-136.28 12.9 -6.39 -73.86 -183.76
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
197.32 220.3 239.37 293.64 350.3
Miscellaneous Expenses
867.34 621.33 981.65 1275.63 1749.12
Operating Profit
339.61 258.89 339.32 458.58 528.64
Other Income
6.69 41.85 59.31 50.42 70.38
Depreciation
36.15 44.78 51.85 74.27 83.39
Interest
7.99 8.45 9.13 11.2 11.66
Profit before tax and exceptio..
302.16 247.51 337.65 423.53 503.97
Exceptional Items
0 0 0 0 0
PBT
302.16 247.51 337.65 423.53 503.97
Provision for Taxation
63.63 60.7 72.33 108.63 121.35
Net Profit
238.54 186.81 265.32 314.9 382.62
NET Profit after MI
238.54 186.81 266.31 313.7 380.58
EPS
5.76 4.51 6.41 6.92 8.4
Operating Profit Margin (%)
24.68 17.37 18.32 21.06 20.16
Net Profit Margin (%)
17.33 12.53 14.38 14.41 14.51

Marksans Pharma Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 43.90 43.90 43.90 43.90 43.80
FII 22.20 22.00 21.30 18.60 15.60
MF 3.40 3.20 3.00 2.80 4.20
Others 1.10 1.00 1.10 0.90 0.90
Shareholder Shares Holding %
Research 360 logo
Download Our App On: